Pre-treatment HIV drug resistance testing cost-effectiveness

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

8 Downloads (Pure)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{2d2edba2b8614377b7837f3fb322a983,

title = "Pre-treatment HIV drug resistance testing cost-effectiveness",

author = "{van de Vijver}, {David AMC} and Nichols, {Brooke E.}",

year = "2020",

month = may,

day = "1",

doi = "10.1016/j.eclinm.2020.100381",

language = "English",

volume = "22",

journal = "EClinicalMedicine",

issn = "2589-5370",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Pre-treatment HIV drug resistance testing cost-effectiveness

AU - van de Vijver, David AMC

AU - Nichols, Brooke E.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85085023049&partnerID=8YFLogxK

U2 - 10.1016/j.eclinm.2020.100381

DO - 10.1016/j.eclinm.2020.100381

M3 - Comment/Letter to the editor

AN - SCOPUS:85085023049

SN - 2589-5370

VL - 22

JO - EClinicalMedicine

JF - EClinicalMedicine

M1 - 100381

ER -